Hemopatch Sealing Haemostatic
The Sealing Haemostat for Sustained Results
Why Choose Hemopatch Sealing Haemostat?
Reduce Post-Operative Complications
Hemopatch Sealing Haemostat may decrease post-operative pancreatic fistulas, CSF leakage, and can help avoid transfusions in cardiac surgery as compared to the standard of care. Reducing these post-operative complications may result in substantial cost savings.1-5*
*Transfusions: Hemopatch Sealing Haemostat 23.5% vs Comparator 34% (p=0.24)
Strong Adherence to the Tissue Surface
Hemopatch Sealing Haemostat rapidly adheres to applied tissue due to the electrophilic cross-linking action of NHS-PEG.6 The patch provides mechanical structure to support friable tissue.6
Designed for Utmost Flexibility
The soft, thin and flexible collagen pad allows easy handling and preparation for MIS applications. No preparation or pre-moistening is required.7
Effective Haemostasis
92% of surgeons rated Hemopatch Sealing Haemostat as highly satisfactory for its ease of use, handling, flexibility/pliability and tissue adherence characteristics in open and laparoscopic procedures.8 Successful hemostasis after two minutes of approximation occurred in 93% of patients.8
Improved PEG Stability with Sustained Tissue Adherence
Room Temperature Storage - No Need for Refrigeration
Extended Shelf- Life- Can be Stored for up to 36 months
HEMOPATCH Sealing Haemostat Indications and Important Safety Information
INDICATIONS:
Hemopatch Sealing Haemostat is indicated as a haemostatic device and surgical sealant across various soft tissues (cardiovascular, connective tissue, parenchyma, serosa, viscera), and dura for procedures in which control of mild or moderate bleeding or leakage of other body fluids or air by conventional surgical techniques is either ineffective or impractical. Hemopatch Sealing Haemostat may be used to augment dura closure techniques to close small dural defects (≤3mm) following traumatic injury, excision, retraction or shrinkage of the dura mater.
CONTRAINDICATIONS:
Do not compress Hemopatch Sealing Haemostat into blood vessels or use intravascularly. The device must not be used in patients with known hypersensitivity to bovine proteins or brilliant blue (FD&C Blue No. 1 (Blue 1)).
WARNINGS:
Hemopatch Sealing Haemostat is not intended to be used in pulsatile, severe bleeding. The use of Hemopatch Sealing Haemostat is not recommended in the presence of an active infection. When used in, around, or in proximity to foramina in bone, areas of bony confine, the spinal cord, the brain and/or cranial nerves, care should be exercised to avoid overpacking (collagens may expand upon absorption of liquid), creating the potential for neural damage. Hemopatch Sealing Haemostat is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for haemostasis and sealing.
For safe and proper use of Hemopatch Sealing Haemostat, refer to full Instructions for Use.